Understanding Antibiotics and Resistance

Why You Should Understand Antibiotics

Antibiotics are among the most important medical tools of the past century. They've turned once-fatal bacterial infections into treatable conditions and made modern surgery, organ transplants, and cancer treatment possible. But there's a growing problem: bacteria are evolving faster than we're developing new drugs to fight them.

According to the WHO's 2025 Global Antibiotic Resistance Surveillance Report, roughly one in six laboratory-confirmed bacterial infections worldwide were resistant to antibiotic treatment in 2023. Between 2018 and 2023, resistance increased in over 40% of monitored antibiotic-bacteria combinations, with average annual increases of 5–15%.

This isn't a distant, abstract crisis. It affects the antibiotics your doctor prescribes for a urinary tract infection, a chest infection, or a wound that won't heal. Understanding how antibiotics work — and how resistance develops — is a genuinely practical skill.

How Antibiotics Work

Antibiotics target features unique to bacterial cells, which is why they can kill bacteria without directly harming your own cells. There are three main strategies.

Destroying the Cell Wall

Many bacteria are surrounded by a rigid structure called a cell wall. Beta-lactam antibiotics — including penicillin, amoxicillin, and cephalosporins — block the construction of this wall. Without it, internal pressure causes the bacterium to burst. This is why these drugs are "bactericidal": they actively kill bacteria rather than just slowing them down.

Blocking Protein Production

Bacteria need to build proteins to grow and function. Antibiotics like tetracyclines, macrolides (e.g. erythromycin, azithromycin), and aminoglycosides interfere with bacterial ribosomes — the molecular machines that assemble proteins. Since bacterial ribosomes are structurally different from human ribosomes, these drugs can target bacteria specifically.

Disrupting DNA Replication

Fluoroquinolones (like ciprofloxacin and levofloxacin) target enzymes bacteria need to copy and repair their DNA. Without functioning DNA, the bacterium can't reproduce or survive.

Broad-Spectrum vs. Narrow-Spectrum

Some antibiotics work against many types of bacteria (broad-spectrum), while others target specific groups (narrow-spectrum). Narrow-spectrum antibiotics are generally preferable because they cause less collateral damage to your body's beneficial bacteria. However, doctors often prescribe broad-spectrum drugs when they can't immediately identify the specific pathogen, which is one factor driving resistance.

How Bacteria Become Resistant

Antibiotic resistance isn't new — it's a natural evolutionary process. But human behaviour is accelerating it dramatically. Here's how resistance develops:

Spontaneous Mutation

Every time bacteria reproduce, there's a small chance of a random DNA mutation. Occasionally, a mutation gives a bacterium an advantage against an antibiotic — perhaps by changing the shape of the protein the drug targets, or by enabling the bacterium to pump the drug out before it can work. In the presence of that antibiotic, the mutant survives while others die. Over time, resistant bacteria dominate.

Gene Sharing Between Bacteria

This is where things get concerning. Bacteria don't just pass genes to their offspring — they can share resistance genes horizontally with other bacteria, even across different species. This happens through several mechanisms: direct transfer between cells (conjugation), uptake of free DNA from the environment (transformation), and transfer via viruses that infect bacteria (transduction). A single resistance gene can spread rapidly through diverse bacterial populations.

Common Resistance Strategies

Bacteria have developed several ways to defeat antibiotics. They can produce enzymes that break down the antibiotic (like beta-lactamase, which destroys penicillin-type drugs). They can modify their own structures so the drug no longer recognises its target. They can activate molecular pumps that expel the antibiotic before it reaches effective concentrations. Or they can develop alternative metabolic pathways that bypass the blocked process entirely.

Why Resistance Is Accelerating

The biological mechanisms above are natural, but several human behaviours are speeding things up considerably.

Overuse and misuse in human medicine. Taking antibiotics for viral infections (colds, flu, most sore throats) does nothing to treat the illness but exposes your bacteria to selective pressure. Stopping a course early, or using leftover antibiotics without medical guidance, also contributes.

Agricultural use. Large quantities of antibiotics are used in livestock farming — often not to treat infections, but to promote growth or prevent disease in crowded conditions. This creates vast reservoirs of resistant bacteria that can transfer to humans through food, water, and the environment.

Inadequate sanitation and infection control. In settings where hygiene is poor, resistant bacteria spread more easily between people. Hospital-acquired infections with resistant pathogens are a major concern worldwide.

Slow drug development. Developing new antibiotics is expensive and commercially unattractive compared to drugs for chronic conditions. The pipeline of new antibiotics has slowed to a trickle just as resistance is surging.

The Current Situation: Key Numbers

The WHO's 2025 GLASS report, drawing on over 23 million confirmed infections from 104 countries, paints a sobering picture:

• Urinary tract infections: One in three showed resistance to standard antibiotics. For E. coli UTIs — among the most common bacterial infections globally — resistance to first-line treatments exceeds 30% in most countries.
• Bloodstream infections: More than 40% of E. coli and over 55% of K. pneumoniae bloodstream infections globally are now resistant to third-generation cephalosporins, the standard first-choice treatment.
• Carbapenem resistance — once extremely rare — is increasing. Carbapenems are often the last effective option for serious gram-negative infections. In Southeast Asia, carbapenem resistance in K. pneumoniae bloodstream infections has reached over 41%.
• Regional variation is stark. In Southeast Asia and the Eastern Mediterranean, roughly one in three infections are drug-resistant. In Europe, it's closer to one in ten. In Africa, resistance exceeds 70% for some pathogen-drug combinations, compounded by limited access to diagnostics and second-line treatments.

The economic projections are equally significant. The World Bank estimates antimicrobial resistance could add $1 trillion in healthcare costs and reduce global GDP by $1–3.4 trillion annually by 2030.

What You Can Do: Practical Steps

Understanding the problem is the first step. Here's how to act on that understanding:

Use Antibiotics Correctly

Only take antibiotics when prescribed by a healthcare professional for a confirmed or strongly suspected bacterial infection. Complete the full course as directed — don't stop early because you feel better, and don't save leftover pills for later. Never share antibiotics or use someone else's prescription.

Don't Pressure Your Doctor

If your doctor says you have a viral infection and don't need antibiotics, trust that judgement. Requesting antibiotics "just in case" contributes directly to resistance. Ask questions if you're unsure, but understand that not prescribing antibiotics is often the more responsible decision.

Prevent Infections in the First Place

Good hygiene — regular handwashing, safe food handling, keeping wounds clean — reduces your need for antibiotics. Staying current with vaccinations prevents bacterial infections (like pneumococcal disease) and viral infections that can lead to secondary bacterial complications.

Be Informed About Food Choices

Where possible, support food producers who use antibiotics responsibly. Look for labels indicating reduced or no antibiotic use in animal products. This isn't about perfection — it's about awareness and shifting demand over time.

Ask About Culture and Sensitivity Testing

For infections that aren't responding to treatment, or for serious infections, ask your doctor whether a culture test could identify the specific bacterium and which antibiotics it's susceptible to. This allows targeted (narrow-spectrum) treatment rather than broad-spectrum guessing.

Key Takeaways

1. Antibiotics work by targeting structures and processes unique to bacteria — cell walls, ribosomes, and DNA replication — but bacteria can evolve to resist each of these attacks.
2. Resistance is a natural process, but human behaviour is dramatically accelerating it through overuse, agricultural practices, and slow development of new drugs.
3. The scale is serious: one in six bacterial infections worldwide are now resistant, and the problem is worsening by 5–15% annually for many drug-bacteria combinations.
4. Individual actions matter: using antibiotics correctly, not demanding them for viral infections, practising good hygiene, and supporting responsible antibiotic use in agriculture all contribute to slowing resistance.
5. Knowledge is protective. Understanding how antibiotics work makes you a better advocate for your own health and a more informed participant in one of the most important public health challenges of our time.

Antibiotics remain powerful tools — but they're a shared, finite resource. The more we understand them, the longer they'll continue to work when we truly need them.